YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Panacryl Sutures
Panacryl Sutures Infection & Additional Surgery
Panacryl sutures also referred to as stitches are used on a regular basis on patients after surgery to help patient’s recovery time. Panacryl sutures do not have to be removed from a patient’s body; they are absorbed into the skin. The FDA approved panacryl sutures in 1999. Ethicon Inc., a division of Johnson & Johnson marketed Panacryl sutures. Ethion Inc. touted panacryl sutures as a device that was one of kind for its absorbability and exceptional strength. Panacryl sutures are braided synthetic absorbable sutures that were used in common soft tissue and orthopedic uses including tendon and ligament repairs and reattachment to bone.Former Johnson & Johsnon Chief Medical Officer, Dr. Joel Lippmann says he objected to the release of the Panacryl suture "whose use resulted in numerous adverse events," but the manufacturer released it anyway and continued to receive reports of "adverse events." In July 2002, panacryl sutures were taken off the market.
Adverse Events Associated with Panacryl Sutures
The following are common adverse complications experienced by some patients after post surgery:
- Elevated rate of infection.
- Sutures unable to absorbing into patients body.
- Suture Granulomas, a bump under the skin, as a result of scar tissue forming around the suture).
- Tunneling, tiny tunnels form around the incision area caused by the suture inhibiting healthy tissue growth).
- Spitting Sutures occurs when the suture is pushed out to the skin surface by the body rejecting the suture).
Legal help for Patients Infected by Panacryl Sutures
If you or a loved one developed an infection or required an additional surgery due to Panacryl sutures, contact Parker & Waichman Alonso LLP for a free case evaluation by a qualified defective medical device attorney. Call 1-800-LAW-INFO (1-800-529-4636) or fill out the short form to the right.
Panacryl SuturesRSS Feed
Chief Medical Officer Blows Whistle On Johnson & Johnson
Dec 13, 2006 | www.courthousenews.com
Johnson & Johnson subsidiary Ethicon fired its chief medical officer because of his insistence that unsafe medical products be recalled, Dr. Joel Lippman claims in Middlesex County Court. Lippman claims that during 15 years in high-ranking medical positions at Ethicon and Ortho McNeil, another J&J subsidiary, Johnson & Johnson repeatedly released or refused to recall dangerous products to which he objected, including the Ortho-Evra birth control patch and Intergel. Both products...
Defective Medical Devices
Quick Facts
Panacryl Sutures Reference Guide
Other Names
Stitches
Date Approved
1999
Manufacturer
Ethicon/Johnson & Johnson
Status
Removed 2002 Approved Uses
Tendon & ligament repairs
Serious Side Effects
Elevated rate of infection
Sutures unable to absorb
Suture Granulomas
Tunneling
Body rejects sutures
Related Topics
Defective Medical Devices
Stitches
Date Approved
1999
Manufacturer
Ethicon/Johnson & Johnson
Status
Removed 2002 Approved Uses
Tendon & ligament repairs
Serious Side Effects
Elevated rate of infection
Sutures unable to absorb
Suture Granulomas
Tunneling
Body rejects sutures
Related Topics
Defective Medical Devices
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS
